Riskpilot← Back to searchSign inGet full accessMSN Läkarkonsult AB
ABActiveOrg 5591977037Morastigen 17General medical practice activities · NACE 8621Est. 20191-4 employees
Revenue 2025
SEK 4,5M
+11% vs 2024
EBITDA margin
31.6%
+14% vs 2024
Equity ratio
85.2%
Financial strength
Net profit 2025
SEK 1,1M
+24% vs 2024
| Revenue | SEK 4,5M | +11% |
| EBITDA | SEK 1,4M | +14% |
| Net profit | SEK 1,1M | +24% |
| Total assets | SEK 4,5M | +25% |
| Equity | SEK 3,9M | +22% |
| Employees | — | — |
Legal name
MSN Läkarkonsult AB
Org number
5591977037
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 mars 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillhandahålla läkartjänster med specialkompetens, kapitalförvaltning genom investering i värdepapper och veteran- bilar samt annan därmed förenlig verksamhet.
Address
Morastigen 17
Email
svenssonmarten99@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3 698 | 3 641 | 4 290 | 4 074 | 4 506 |
| Staff expenses | — | −2 432 | −2 567 | −2 663 | −2 914 |
| EBITDA | 1 203 | 1 000 | 1 628 | 1 248 | 1 424 |
| Depreciation & amort. | −0 | — | −16 | −104 | −104 |
| EBIT | 1 203 | 1 000 | 1 611 | 1 144 | 1 320 |
| Net financials | 118 | −171 | 6 | 8 | 113 |
| Profit before tax | 1 320 | 829 | 1 617 | 1 152 | 1 433 |
| Tax | −286 | −206 | −333 | −237 | −297 |
| Net profit | 1 034 | 623 | 1 284 | 915 | 1 137 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 895 | 2 512 | 3 660 | 3 644 | 4 545 |
| Equity | 2 592 | 2 290 | 3 099 | 3 164 | 3 871 |
| Long-term debt | 31 | 0 | 169 | 86 | 0 |
| Short-term debt | 272 | 222 | 391 | 394 | 674 |
| Total debt | 303 | 222 | 561 | 479 | 674 |
EBITDA margin
31.6%
This company
15.8%
Market median
+100% vs market
20212025
Equity ratio
85.2%
This company
38.2%
Market median
+123% vs market
20212025
Return on equity
29.4%
This company
18.4%
Market median
+60% vs market
20212025
Net profit margin
25.2%
This company
8.1%
Market median
+211% vs market
20212025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MSN Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Marie Gabrielsson | Audit | 0 companies |
| Katarina Svensson | Deputy Board Member | 0 companies |
| Lars Åke Mårten Svensson | Board of Directors | 0 companies |